Eye-opening care. Life-changing results. Far-reaching implications.

At Chu Vision, we help patients move forward with confidence by providing clear, concise information upfront and kind, considerate care throughout. We are also committed to advancing the field of eye care. Learn more about how we have taken a leadership role within our professional community—locally and globally—to help bring leading-edge technologies to market.

Current Clinical Trials

+ Cataracts

Bausch & Lomb Viscoelastic for use in cataract Surgery

Cohesive viscoelastics are substances used to maintain space in the eye while a natural lens is removed and an intraocular lens is inserted during cataract surgery. This study compares the safety and effectiveness of a cohesive viscoelastic from Bausch & Lomb (CVisc50) to a control product from and Alcon (ProVisc)

Carl Zeiss Meditec MICOR

Current cataract extraction practice uses phacoemulsification, which is a high-energy ultrasound technology.

This study evaluates the clinical outcomes after use of low-energy micro-interventional irrigation/aspiration port (MICOR-304) to remove the lens prior to intraocular lens insertion in subjects undergoing routine cataract surgery.

Bausch & Lomb Trifocal IOL

We are currently participating in a clinical research study of a new investigational multifocal (Trifocal) intraocular lens (IOL) here in our Bloomington office. Multifocal IOLs have been successfully developed to improve your full range of vision — near, intermediate, and far distances.

+ Dry Eye

Greenlight clinical eye drop for dry eye disease

Dry Eye Syndrome is a common problem causing irritated, scratchy, gritty sensations in the eyes due to insufficient, or poor-quality tears. Dryness can also cause blurred vision.

This clinical trial evaluates the ocular safety, tolerability, and efficacy of topical administration of an eye drop (SURF-200 ophthalmic solution) in patients with a diagnosis of Dry Eye Disease and experiencing an episodic flare up.

+ Fuchs' Dystrophy

Aerie Pharmaceuticals eye drop for Fuch’s Dystrophy

Fuchs' (pronounced fewks) Dystrophy causes fluid buildup in the cornea. This creates swelling and can lead to discomfort, glare, and blurred or cloudy vision.

This study will evaluate the reduction in the corneal swelling after use of the ey drop netarsudil, either once or twice daily, in patients diagnosed with Fuch's Dystophy.

Committed to Advancing the Field of Ophthalmology Through Research - Watch to learn more as we have participated in over 90 research studies!

Clinical Trails FAQs

Ask Chu which procedure is right for you.